Today: December 28, 2024
October 26, 2022
1 min read

For the first time, an Argentine vaccine against the coronavirus completes phase I

For the first time, an Argentine vaccine against the coronavirus completes phase I

The vaccine national Arvac Cecilia Grierson (Arvac CG) against the coronavirus, developed by Conicet, the National University of San Martín (Unsam) and the Cassará Laboratory, “is safe”.

It is the first time that a antibody injection of infectious diseases is designed and developed entirely in our country, in addition, it completes the clinical studies of phase I. “It is very immunological”, revealed the report on the clinical trials in which 80 healthy people previously participated vaccinated against SARS-CoV-2 (coronavirus).

Source link

Latest Posts

They celebrated "Buenos Aires Coffee Day" with a tour of historic bars - Télam
Cum at clita latine. Tation nominavi quo id. An est possit adipiscing, error tation qualisque vel te.

Categories

Workers born in March can withdraw emergency aid
Previous Story

Caixa asks for five days to release consigned from Auxílio Brasil

They caught two subjects for diversion of chemical substances
Next Story

They caught two subjects for diversion of chemical substances

Latest from Blog

How do Ukrainians see the year 2025?

How do Ukrainians see the year 2025?

Embed note December 27, 2024, 10:24 PM December 27, 2024, 10:24 PM Ukraine has had a difficult year. Following the Ukrainian army’s offensive in the Kursk region in the summer, Russia intensified
Go toTop